Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism-Reference-Cited by-同舟云学术

Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism

Published:2024-01 Issue: Volume:233 Page:165-172
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Rueda-Camino José Antonio,Barba Raquel,Otálora Sonia,Bura-Riviere Alessandra,Visonà Adriana,Mahé Isabelle,Alda-Lozano Alicia,Alfonso Megido Joaquín,Pacheco-Gómez Nazaret,Rosovsky Rachel P.,Monreal Manuel

Funder

Sanofi España

Publisher

Elsevier BV

Subject

Hematology

Reference43 articles.

1. Global burden of thrombosis: epidemiologic aspects;Wendelboe;Circ. Res.,2016

2. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany;Keller;Eur. Heart J.,2020

3. Obesity as a risk factor for venous thromboembolism recurrence: a systematic review;Ntinopoulou;Medicina (Kaunas),2022

4. Cardiovascular risk factors and venous thromboembolism: a meta-analysis;Ageno;Circulation,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials;Thrombosis Research;2024-06

2. Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study;Journal of Clinical Medicine;2024-03-14

3. International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants;Clinical and Applied Thrombosis/Hemostasis;2024-01